100000 - Document - Cover Page
link:presentationLink
link:calculationLink
link:definitionLink
100010 - Statement - Condensed Consolidated Statements of Profit or (Loss) and Other Comprehensive Income or (Loss)
link:presentationLink
link:calculationLink
link:definitionLink
100020 - Statement - Condensed Consolidated Statements of Profit or (Loss) and Other Comprehensive Income or (Loss) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100030 - Statement - Consolidated Statements of Financial Position
link:presentationLink
link:calculationLink
link:definitionLink
100040 - Statement - Consolidated Statements of Changes in Equity
link:presentationLink
link:calculationLink
link:definitionLink
100050 - Statement - Consolidated Cash Flow Statements
link:presentationLink
link:calculationLink
link:definitionLink
100060 - Disclosure - General Information
link:presentationLink
link:calculationLink
link:definitionLink
100070 - Disclosure - Summary of Material Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
100080 - Disclosure - Significant Accounting Judgements and Estimates
link:presentationLink
link:calculationLink
link:definitionLink
100090 - Disclosure - Significant Events in the Reporting Period
link:presentationLink
link:calculationLink
link:definitionLink
100100 - Disclosure - Revenue
link:presentationLink
link:calculationLink
link:definitionLink
100110 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
100120 - Disclosure - Share-based Payment
link:presentationLink
link:calculationLink
link:definitionLink
100130 - Disclosure - Share Capital
link:presentationLink
link:calculationLink
link:definitionLink
100140 - Disclosure - Treasury Shares
link:presentationLink
link:calculationLink
link:definitionLink
100150 - Disclosure - Financial Assets and Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
100160 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
100170 - Disclosure - Summary of Material Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
100180 - Disclosure - Revenue (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100190 - Disclosure - Share-based Payment (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100200 - Disclosure - Treasury Shares (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100210 - Disclosure - Financial Assets and Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100220 - Disclosure - Summary of Material Accounting Policies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100230 - Disclosure - Significant Accounting Judgements and Estimates - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100240 - Disclosure - Significant Events in the Reporting Period - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100250 - Disclosure - Revenue - Schedule of Revenue Recognized in Unaudited Condensed Consolidated Interim Statements of Profit or Loss (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100260 - Disclosure - Revenue - Schedule of Revenue Recognized in Consolidated Statements of Profit or Loss (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100270 - Disclosure - Revenue - Schedule of Revenue From Sale of Commercial Products (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100280 - Disclosure - Revenue - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100290 - Disclosure - Segment Information - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100300 - Disclosure - Share-based Payment - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100310 - Disclosure - Share-based Payment - Schedule of Warrant Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100320 - Disclosure - Share-based Payment - Summary Of Share Based Payment (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100330 - Disclosure - Share Capital - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100340 - Disclosure - Treasury Shares - Summary of Holding of Treasury Shares (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100350 - Disclosure - Financial Assets and Liabilities - Schedule of Financial Assets and Financial Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100360 - Disclosure - Financial Assets and Liabilities - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100370 - Disclosure - Financial Assets and Liabilities - Summary of Fair Value Hierarchy (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100380 - Disclosure - Financial Assets and Liabilities - Movements in Level 3 Fair Value Measurements (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100390 - Disclosure - Financial Assets and Liabilities - Liquidity Risk Management (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100400 - Disclosure - Subsequent Events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Financial liabilities at fair value, class [member]
Financial liabilities at fair value, class [member]
Financial assets by category
Categories of financial assets [abstract]
Total current financial liabilities
Current financial liabilities
Current liabilities
Geographical areas [domain]
Statement of changes in equity [line items]
Summary of Marketable securities
Disclosure Detailed Information About Marketable Securities [Text Block]
Disclosure detailed information about marketable securities.
Entity Addresses, Address Type [Axis]
Investing activities
Cash flows from (used in) investing activities [abstract]
Adjustments for provisions
Provisions
Repayments of borrowings
Repayments of borrowings, classified as financing activities
Repayment of borrowings
Financing activities
Cash flows from (used in) financing activities [abstract]
Borrowings threshold percentage of sale price per share for redemption
Borrowings Threshold Percentage Of Sale Price Per Share For Redemption
Borrowings threshold percentage of sale price per share for redemption.
Carrying amount [member]
Fair Value Hierarchy Carrying Amount [member]
Fair value hierarchy carrying amount.
Royalty payment ending period.
Royalty Payment Ending Period
Royalty payment ending period
Total assets
Assets at beginning of period
Assets at end of period
Assets
Percentage of reasonably possible decrease in unobservable input, liabilities
Percentage of reasonably possible decrease in unobservable input, liabilities
Equity
Equity [abstract]
Counterparties [domain]
Total non-current contract liabilities
Contract liabilities
Non-current contract liabilities
Tax income (expense)
Total tax expense (income)
Tax expense (income)
Income taxes (expenses)
Reversal of income taxes
Statement of cash flows [abstract]
Weighted Average Duration Of Marketable Securities
Weighted Average Duration Of Marketable Securities Explanatory
Weighted average duration of marketable securities explanatory.
Adjustments for non-cash items:
Adjustments to reconcile profit (loss) [abstract]
Settled during the period
Number Of Other Equity Instruments Settled In Share Based Payment Arrangement
Number of other equity instruments settled in share based payment arrangement.
Settled during the period
Vested at the balance sheet date
Weighted average exercise price of other equity instruments vested in sharebased payment arrangement
Weighted average exercise price of other equity instruments vested in share-based payment arrangement
Treasury Shares Of Nominal Value
Treasury shares of nominal value.
March 31, 2025 (Nominal values)
January 1, 2025 (Nominal values)
Transferred during the period
Number Of Other Equity Instruments Transferred In Share Based Payment Arrangement
Number of other equity instruments transferred in share based payment arrangement.
Treasury Shares Holding In Percentage Of Total Outstanding Shares
Treasury shares holding in percentage of total outstanding shares.
March 31, 2025 (Holding in % of total outstanding shares)
January 1, 2025 (Holding in % of total outstanding shares)
Adjustments For Non Cash Consideration Regarding Revenue
Adjustments for non cash consideration regarding revenue.
Non-cash consideration relating to revenue
Convertible debt current abstract.
Convertible Debt Current [Abstract]
Convertible notes, matures in April 2028
Non-adjusting events after reporting period [domain]
Timing of transfer of goods or services [domain]
Disclosure of share-based payment arrangements [text block]
Share-based Payment
Retained earnings [member]
Accumulated Deficit [member]
Third party investors.
Third Party Investors [Member]
Third Party Investors [Member]
Conversion price per share
Conversion Price Per Share
Conversion price per share.
Other comprehensive income that will be reclassified to profit or loss, net of tax
Other comprehensive income/(loss), net of tax
Other comprehensive income/(loss) for the period, net of tax
Total non-current financial liabilities
Non-current financial liabilities
Non-current liabilities
Document Information [Table]
Non-current lease liabilities
Lease liabilities
Non-current lease liabilities
Share Based Compensation Expense
Share-based payment
Adjustments for share-based payments
Disclosure of detailed information about financial instruments [abstract]
Disclosure of non-adjusting events after reporting period [table]
Total current liabilities
Current liabilities
Current liabilities
Historical volatility for shares, measurement input [member]
Entity Central Index Key
Counterparties [axis]
Total selling, general and administrative expense
Selling, general and administrative expenses
Selling, general and administrative expense
Prepayments
Adjustments for decrease (increase) in prepaid expenses
Percentage of reasonably possible increase in unobservable input, liabilities
Percentage of reasonably possible increase in unobservable input, liabilities
Components of equity [domain]
Categories of financial liabilities [axis]
Categories of financial liabilities [axis]
Classes of share capital [domain]
Vesting
Vesting [Member]
Adjustments for increase (decrease) in trade and other payables
Trade payables, accrued expenses and other liabilities
Total current inventories
Inventories
Current inventories
Revision of Prior Period [Axis]
Investments in associates reported in separate financial statements
Investments in associates
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
Summary of Weighted Average Exercise Prices and Movements in Warrants
Convertible Senior Notes
Convertible senior notes
Convertible Senior Notes
Convertible senior notes.
Disclosure of terms and conditions of share-based payment arrangement [abstract]
Restricted Stock Units and Performance Stock Unit [Member]
Restricted stock units and performance stock unit.
Customer [Axis]
Derivative Liabilities
Derivative liabilities
Non-current derivative financial liabilities
Total adjustments for increase (decrease) in deferred income including contract liabilities
Adjustments for increase (decrease) in deferred income including contract liabilities
Contract liabilities
Revenue from contracts with customers
Recognized as revenue
Non-adjusting events after reporting period [axis]
Non-adjusting events after reporting period [axis]
Royalty funding liabilities
Contractual Undiscounted Cashflow of Royalty Funding Liabilities
Contractual undiscounted cashflow of royalty funding liabilities.
Exchange rate for percentage of net sales to royalty payment.
Exchange Rate For Percentage Of Net Sales To Royalty Payment
Net revenue from sales interest payment in percentage in exchange for funding
Total intangible assets and goodwill
Intangible assets and goodwill at end of period
Intangible assets and goodwill at beginning of period
Intangible assets and goodwill
Intangible assets
Borrowings threshold trading days for redemption
Borrowings Threshold Trading Days For Redemption
Borrowings Threshold Trading Days For Redemption.
Disclosure Of Financial Assets And Liabilities [text block]
Disclosure Of Financial Assets And Liabilities [text block]
Schedule of Financial Assets and Financial Liabilities
Cover [Abstract]
Number of shares authorised
Treasury Shares
Disclosure Of Information About Treasury Shares Explanatory
Disclosure of information about treasury shares explanatory.
Treasury shares holding in percentage transferred under stock incentive programs.
Treasury Shares Holding In Percentage Transferred under stock incentive programs
Transferred under stock incentive programs (Holding in % total outstanding shares)
Disclosure of maturity analysis for derivative financial liabilities [line items]
Proportion of ownership interest in associate
Present ownership percentage
Weighted Average Duration Of Marketable Securities Noncurrent
Weighted Average Duration Of Marketable Securities Noncurrent Explanatory
Weighted average duration of Marketable securities noncurrent explanatory.
Impairment of property, plant and equipment
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment
Classes of share capital [axis]
Vested at the balance sheet date
Number of other equity instruments vested in share-based payment arrangement
Number of other equity instruments vested in share-based payment arrangement.
Disclosure of changes in accounting estimates [table]
Performance obligations [domain]
Total property, plant and equipment
Property, plant and equipment
Property, plant and equipment at beginning of period
Property, plant and equipment at end of period
Property, plant and equipment
Granted during the period
Weighted average exercise price of other equity instruments granted in share-based payment arrangement
Increase in share capital
Increase (decrease) in number of ordinary shares issued
Increase decrease In treasury shares acquired from third parties.
Increase Decrease In Treasury Shares Acquired From Third Parties
Acquired from third-parties (Holding)
Borrowings
Borrowings [abstract]
Cost of sales
Cost of sales
Cost of sales
Operating activities
Cash flows from (used in) operating activities [abstract]
Number of warrants outstanding.
Number of warrants outstanding
Warrants outstanding
Warrants outstanding
Payments to acquire or redeem entity's shares
Payments to acquire or redeem entity's shares
Acquisition of treasury shares, net of transaction costs
Classes of other provisions [domain]
Components of equity [axis]
Components of equity [axis]
Total non-current financial assets
Non-current financial assets
Non-current assets
RSU Net Settlement [member]
RSU net settlement.
RSU Net Settlement [member]
Forfeited during the period
Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement
Subsequent Events
Disclosure of events after reporting period [text block]
Basis of Preparation
Disclosure of basis of preparation of financial statements [text block]
Collaborations and license agreements [Member]
Collaborations And License Agreements [Member]
Collaborations and license agreements.
Current assets
Current assets [abstract]
Disclosure of detailed information about financial instruments [table]
Disclosure of detailed information about financial instruments [table]
Share-based payment arrangement, restricted stock unit, activity.
Sharebased Payment Arrangement, Restricted Stock Unit, Activity [Table]
Disclosure Of Holding Of Treasury Shares [Line Items]
Disclosure of holding of treasury shares.
Sales rebates and product returns in U.S. market [member]
Sales Rebates And Product Returns In U.S. Market [Member]
Sales rebates and product returns in U.S. market.
Summary of Maturity Analysis For Financial Liabilities
Maturity Analysis For Financial Liabilities [Text Block]
Maturity analysis for financial liabilities.
Percentage of entity's revenue
Perentage of sale to commercial products
Borrowings
Total borrowings
Borrowings (excluding lease liabilities)
Share-based payment arrangement, restricted stock unit, activity.
Sharebased Payment Arrangement, Restricted Stock Unit, Activity [Line Items]
Share Capital
Disclosure of share capital, reserves and other equity interest [text block]
Assets [abstract]
Revenue from sale of goods
Commercial products
Revenue from commercial products
Inventories
Adjustments for decrease (increase) in inventories
Ending balance
Beginning balance
Derivative liabilities
Derivative financial liabilities
Royalty funding liabilities
Royalty funding liabilities.
Royalty funding liabilities
Disclosure of fair value measurement of liabilities [abstract]
Amendment Flag
Hedging instruments [domain]
Statement of changes in equity [abstract]
Total issued capital
Share capital
Issued capital
Basic earnings (loss) per share
Total basic earnings (loss) per share
Basic earnings/(loss) per share
Number of shares used for calculation (basic and diluted)
Weighted average number of ordinary shares used in calculating basic earnings per share
Total financial assets
Financial assets
Financial assets at beginning of period
Financial assets at end of period
Financial assets
Transfered
Derivative Financial Liabilities at Fair Value Transfered
Derivative financial liabilities at fair value transfered.
Non Cash Gain Recognized On Ownership Interest In Associate
Non cash gain recognized on ownership interest in associate.
Non-cash gain recognized
Liquidity risk [member]
Liquidity risk [member]
Classes of liabilities [domain]
Forfeited during the period
Number of other equity instruments forfeited in share-based payment arrangement
Within 1 year [member]
Not later than one year [member]
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
Total financial liabilities
Contractual Undiscounted Cashflow Of Financial Liabilities
Contractual undiscounted cashflow of financial liabilities.
Bottom of range [member]
Bottom of range [member]
Disclosure of classes of share capital [abstract]
Presentation of leases for lessee [abstract]
Share Premium [member]
Asia [Member]
Sale or issue of treasury shares
Transfer under stock incentive programs
Financial liabilities by category
Categories of financial liabilities [abstract]
Increase (decrease) through share-based payment transactions, equity
Share-based payment (Note 7)
Treasury Shares Holding In Percentage Acquired From Third Parties
Treasury shares holding in percentage acquired from third parties.
Acquired from third parties (Holding in % of total outstanding shares)
Share-based payment arrangement, award type.
Share based Payment Arrangement, Award type [Axis]
Significant Events In The Reporting Period LineItems
Significant events in the reporting period.
Finance costs
Finance expenses
Reversal of finance expenses
Finance costs
Summary of Share Based Payment
Sharebased Payment Arrangement, Restricted Stock Unit, Activity [Text Block]
Sharebased payment arrangement, restricted stock unit, activity.
Reversal of finance income
Finance income
Finance income
Number of shares outstanding
Number of shares outstanding at beginning of period
Number of shares outstanding at end of period
Ordinary shares [member]
Net proceeds after deduting offering expenses
Proceeds From Royalty Funding Liabilities Excluding Offering Expenses
Proceeds from royalty funding liabilities excluding offering expenses.
Segment Information
Disclosure of entity's operating segments [text block]
Financial liabilities at amortised cost, class [member]
Financial liabilities at amortised cost, class [member]
Schedule of Revenue From Sale of Commercial Products
Disclosure Of Revenue To Commercial Products Explanatory
Disclosure of revenue to commercial products explanatory.
Borrowings in arrears default payment start date
Borrowings In Arrears Default Payment Start Date
Borrowings in arrears default payment start date.
Antidilutive Securities Not Included In Diluted Earnings Per Share [Axis]
Antidilutive securities not included in diluted earnings per share.
Disclosure of voluntary change in accounting policy [abstract]
Types of share-based payment arrangements [domain]
Income statement [Axis].
Income Statement [Axis]
Financial assets measured at amortized cost
Financial assets at amortised cost
Categories of financial liabilities [domain]
Classes of financial liabilities [domain]
Disclosure of Operating Segments [abstract]
Revenue [abstract]
Change to Presentation of Borrowings
Disclosure of reclassifications or changes in presentation [text block]
Major customers [axis]
Major customers [axis]
Financial assets at amortised cost, class [member]
Classes of financial instruments [axis]
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Increase/(decrease) in cash and cash equivalents
2026
Two Thousand And Twenty six [Member]
Two thousand and twenty six.
Disclosure of initial application of standards or interpretations [text block]
New and Amended Standards and Interpretations
New and Amended IFRS Accounting Standards and Interpretations
Lease liabilities
Total lease liabilities
Lease liabilities
Lease liabilities
Attributable to owners of the Company
Profit (loss), attributable to owners of parent
Attributable to owners of the Company
Comprehensive income, attributable to owners of parent
Beginning balance
Ending balance
Number of other equity instruments outstanding in share-based payment arrangement
Beginning balance
Ending balance
Trade payables
Trade payables and accrued expenses
Novo Nordisk.
Novo Nordisk [member]
Novo Nordisk [member]
Stock Repurchase Program Authorized Amount
Stock repurchase program authorized amount.
Share repurchase program authorized amount
Condensed Income Statements, Captions [Line Items]
Royalty payment beginning period.
Royalty payment beginning period
Adjustment to Prior Periods Estimates and Assumptions [Member]
Revision of Prior Period, Adjustment [Member]
Convertible notes current.
Convertible Notes Current
Convertible notes current
Convertible notes current
Disclosure Of Warrant Activity [line items]
Disclosure Of Warrant Activity [line items]
Disclosure Of Warrant Activity [line items]
Board members of group.
Board members of group [member]
Treasury Shares Acquired From Third Parties
Treasury shares acquired from third parties.
Acquired from third parties (Nominal values)
Effect of exchange rate changes on balances held in foreign currencies
Effect of exchange rate changes on cash and cash equivalents
Purchase of treasury shares
Acquisition of treasury shares (Note 9)
Acquisition of treasury shares (Note 9)
Disclosure of fair value measurement of liabilities [line items]
Balances with banks
Bank deposits
Revision of Prior Period [Domain]
Other financial liabilities
Other liabilities (excluding indirect tax, and employee related payables)
Revenue From Rendering Of Services and Clinical Supply
Revenue from rendering of services and clinical supply.
Rendering of services and clinical supply
Principal amount
Notional amount
Europe [Member]
Europe [member]
Disclosure of detailed information about financial instruments [line items]
Disclosure of detailed information about financial instruments [line items]
Repurchase of Shares Value
Repurchase of shares value.
Repurchase of shares, value
Income tax receivables
Current tax assets, current
Amount multiplied to purchase price minus revenue interest payments paid to purchaser on effective date of buy-out notice provided on or prior to period as buyout amount
Amount multiplied to purchase price minus revenue interest payments paid to purchaser on effective date of buy-out notice provided on or prior to period as buyout amount.
Disclosure of summary of significant accounting policies [table]
Disclosure of summary of significant accounting policies [table]
Disclosure of summary of significant accounting policies [table]
Statement of comprehensive income [abstract]
Conversion rate per note
Conversion Rate Per Note
Conversion rate per note.
Significant Accounting Judgements and Estimates
Disclosure of accounting judgements and estimates [text block]
Trade receivables
Current trade receivables
Categories of related parties [axis]
Convertible senior notes
Contractual Undiscounted Cashflow Of Convertible Senior Notes
Convertible senior notes.
Disclosure of general information.
Disclosure of General Information [Abstract]
Increase (decrease) through transactions with owners, equity
Capital increase (Note 8)
Major customers [domain]
Restricted share units [member]
RSUs
Disclosure of maturity analysis for derivative financial liabilities [abstract]
Document Type
Reserve of exchange differences on translation [member]
Foreign Currency Translation Reserve [member]
Disclosure of operating segments [table]
Disclosure of operating segments [table]
Significant Events In The Reporting Period Table
Significant Events In The Reporting Period.
Fair value [member]
At fair value [member]
Other current financial liabilities
Other current liabilities
Net cash flows from (used in) operating activities
Cash flows from (used in) operating activities
Cash flows from/(used in) operating activities
Document Fiscal Period Focus
Disclosure of non-adjusting events after reporting period [abstract]
Ending balance
Total current provisions
Provisions
Current provisions
Beginning balance
Visen Pharmaceuticals [Member]
Visen Pharmaceuticals [Member]
Visen Pharmaceuticals Member
VISEN [member]
American depository shares [member]
American depository shares.
Address Type [Domain]
Classes of financial instruments [domain]
Other receivables
Other non-current receivables
Types of risks [domain]
Total non-current assets
Non-current assets
Unobservable inputs [domain]
Funding received in exchange of royalty payments
Funding received in exchange of royalty payments.
Funding received in exchange of royalty payments
Royalty pharma united states yorvipath.
Royalty Pharma United States Yorvipath [Member]
Royalty Pharma U.S. Yorvipath [member]
Total non-current portion of non-current borrowings
Borrowings
Non-current portion of non-current borrowings
Types of risks [axis]
Types of risks [axis]
Diluted earnings (loss) per share
Total diluted earnings (loss) per share
Diluted earnings/(loss) per share
Weighted Average Duration Of Marketable Securities Current
Weighted Average Duration Of Marketable Securities Current Explanatory
Weighted average duration of marketable securities current.
Total trade and other payables
Trade payables
Trade and other payables
Trade payables, accrued expenses and other liabilities
Top of range [member]
Top of range [member]
Summary of Holding of Treasury Shares
Disclosure of treasury shares [text block]
Current liabilities
Current liabilities [abstract]
Percentage of vesting rights for share-based payment arrangement.
Percentage of vesting rights for share-based payment arrangement
Percentage of vesting rights
Current lease liabilities
Current lease liabilities
Antidilutive Securities Not Included In Diluted Earnings Per Share [Member]
Antidilutive securities not Included In diluted earnings per share.
After 5 years [member]
Later than three years and not later than five years [member]
Document Period End Date
Net gains (losses) on disposals of property, plant and equipment
Gains (losses) on disposals of property, plant and equipment
Reversal of (gain)/loss on disposal of property, plant and equipment
Non-current assets [abstract]
Non-current assets
Other current liabilities abstract.
Other Current Liabilities [Abstract]
Other current liabilities
Vesting Of Shares [Axis]
Vesting of shares.
Number of Ordinary Share Related to Repurchase of Shares
Number of ordinary share Related to repurchase of shares.
Number of ordinary share Related to repurchase of shares
Research and development expense
Research and development expenses
Share based compensation costs
Expense from share-based payment transactions with employees
Total current prepayments
Prepayments
Current prepayments
Payment Term Of Customers
Payment Term Of Customers
Payment term of customers.
"Right-to-use" licenses
Licence fee income
Licenses
Profit (loss) before tax
Profit/(loss) before tax
Proceeds from borrowings, classified as financing activities
Proceeds from borrowings
Net proceeds from borrowings
Net proceeds from borrowings
Disclosure of changes in accounting estimates [abstract]
Gross profit
Gross profit
Gross profit
Other liabilities
Other current liabilities
Types of antidilutive instruments [domain]
Royalty Pharma.
Royalty Pharma [member]
Hedging instruments [axis]
Issued capital [member]
Share Capital [member]
Performance stock unit program member.
Performance Stock Unit Program [Member]
Treasury shares transferred under stock incentive program nominal value.
Treasury Shares Transferred Under Stock Incentive Program Nominal Value
Transferred under stock incentive programs (Nominal values)
Performance obligations [axis]
Balance of equity
Balance of equity
Total equity
Equity
Equity
Equity
Equity
Disclosure of summary of significant accounting policies [abstract]
Disclosure of summary of significant accounting policies [abstract]
Types of interest rates [axis]
Types of interest rates [axis]
Total current contract liabilities
Contract liabilities
Current contract liabilities
Later than one year [member]
Employees and consultants.
Employees and Consultants [Member]
Employees and consultants [member]
Profit loss.
Profit Loss [Member]
Borrowings Interest Rate
Borrowings, interest rate
Events After Reporting Period [Member]
Events after reporting period.
Events After Reporting Period [member]
Borrowings condition for redemption
Borrowings Condition For Redemption
Borrowings condition for redemption.
Profit or loss [abstract]
Treasury Shares [member]
Fair Value of Convertible Notes
Fair Value of Convertible Notes
Fair value of convertible notes.
Marketable securities
Total current financial assets
Current financial assets
Current assets
Total current assets
Current assets
Other receivables
Other receivables (excluding indirect tax receivables)
Summary of significant accounting policies.
Summary of Significant Accounting Policies [abstract]
Summary of Significant Accounting Policies [abstract]
Royalty Funding Liabilities
Disclosure Of Royalty Funding Liabilities Explanatory
Disclosure of royalty funding liabilities.
Share Repurchase Program and RSU Net Settlement [member]
Share Repurchase Program and RSU Net Settlement [member]
Share repurchase program and RSU net settlement.
Share price
Share Price Applied For Valuation
Share price applied for valuation.
Multiple of the purchase price were royalty payment will cease
Multiple Of Purchase Price, Were Royalty Payment Will Cease
Multiple of purchase price, were royalty payment will cease.
Marketable Securities Explanatory
Marketable securities explanatory.
Marketable securities
Disclosure of performance obligations [line items]
Share Repurchase Program [member]
Share repurchase program.
Share Repuchase Program [member]
Convertible Senior Notes and Derivative Liabilities
Description Of Accounting Policy For Convertible Notes And Derivative Liabilities [Policy Text Block]
Description of accounting policy for convertible notes and derivative liabilities.
Classes of financial liabilities [axis]
Significant Events In the Reporting Period
Significant Events In The Reporting Period [Text Block]
Significant Events In The Reporting Period Text Block.
Convertible Senior Notes [Member]
Convertible senior notes [Member].
Current Fiscal Year End Date
Financial liabilities at fair value through profit or loss, category [member]
Financial liabilities measured at fair value through profit or loss [member]
Disclosure of operating segments [line items]
Disclosure of operating segments [line items]
Revenue
Classes of liabilities [axis]
Deferred tax liabilities
Deferred tax liabilities
Borrowings
Contractual Undiscounted Cashflow Of Financial Borrowings
Contractual undiscounted cashflow of financial borrowings.
Number of shares in entity held by entity or by its subsidiaries or associates
Common stocks non-diluted basis
Shares held
Number of reportable segment
Number of reportable operating segments
Number of reportable operating segments.
Entity Registrant Name
Share-based payment arrangement, award type.
Sharebased Payment Arrangement, Award type [Domain]
Disclosure of classes of share capital [line items]
Derivative Financial Liabilities at Fair Value Remeasurement Recognized in Financial Income Or Expense
Derivative financial liabilities at fair value remeasurement recognized in financial income or expense.
Remeasurement recognized in finance (income) or expense
Performance Stock Units [Member]
Performance stock units.
Multiple of the purchase price were royalty payment will cease
Multiple of the Purchase Price, were Royalty Payment will cease
Multiple of the purchase price, were royalty payment will cease.
Non-current liabilities
Non-current liabilities [abstract]
Payment for repurchase of shares
Payment For Repurchase Of Shares
Payment for repurchase of shares.
Disclosure of Revenue to Commercial Customers Explanatory
Disclosure of revenue to commercial customers explanatory.
Schedule of Revenue Attributable to Commercial Products
Other receivables
Other current receivables
Borrowings
Current borrowings
Summary of Significant Accounting Policies
Disclosure Of Summary Of Significant Accounting Policy Explanatory
Disclosure of summary of significant accounting policy.
Summary of Material Accounting Policies
Reserve of share-based payments [member]
Share-based Payment Reserve [member]
Disclosure of treasury shares.
Disclosure of treasury shares [abstract]
Categories of non-current financial assets [abstract]
Classified in the statement of financial position
2025
Two thousand and twenty five [Member]
Two thousand and twenty five.
Number of commercial customers.
Number of commercial customers
Number of commercial customers
Purchase of intangible assets and property, plant and equipment
Purchase of intangible assets and property, plant and equipment.
Acquisition of intangible assets and property, plant and equipment
2024
Two Thousand And Twenty four [Member]
Two thousand and twenty four.
Share Price Measurement Input [Member]
Share price measurement input [member].
Categories of non-current financial liabilities [abstract]
Classified in the statement of financial position
Statement of changes in equity [table]
Revenue
Disclosure of revenue [text block]
Classification Of Related Party [Domain]
Classification Of Related Party [Domain]
Proceeds from exercise of warrants
Net proceeds from exercise of warrants
Proceeds from exercise of warrants
Derivatives [member]
2023
Two Thousand And Twenty Three [Member]
Two thousand and twenty three.
Share of profit (loss) of associates accounted for using equity method
Share of profit/(loss) of associates
Share of (profit)/loss of associates
Within 1 to 5 years [member]
Later than one year and not later than five years [member]
Summary of Fair Value Hierarchy
Disclosure of Summary of Fair Value Hierarchy [Table Text Block]
Disclosure of summary of fair value hierarchy.
Warrants [member]
Warrant1 [member]
Warrants.
U.S. SKYTROFA.
United States Skytrofa [member]
U.S. SKYTROFA [member]
SKYTROFA [member]
Disclosure Of Holding Of Treasury Shares [Table]
Disclosure of holding of treasury shares.
Revenue [table]
Revenue table.
Condensed Income Statement [Table]
Revenue from external customers (geographical)
Disclosure of geographical areas [abstract]
Revenue (geographical)
Trade payables
Contractual Undiscounted Cashflow Of Trade Payables And Other Payables
Contractual undiscounted cashflow of trade payables and other payables.
Granted during the period
Number of other equity instruments granted in share-based payment arrangement
Granted
Increase decrease in treasury shares transferred under stock incentive program.
Increase Decrease In Treasury Shares Transferred Under Stock Incentive Program
Transferred under stock incentive programs (Holding)
Collaboration partners and license agreements [Member]
Collaboration partners and license agreements [Member]
Collaboration Partners and License Agreements.
Proceeds From Issuance Of Notes
Proceeds from issue of bonds, notes and debentures
Receivables
Adjustments for decrease (increase) in trade and other receivables
Funding received
Funding received in exchange of royalty payments
Funding received in exchange.
Funding received in exchange
Disclosure of maturity analysis for derivative financial liabilities [table]
Payment Of Withholding Taxes Under Stock Incentive Programs
Payment of withholding taxes under stock incentive programs.
Payment of withholding taxes under stock incentive programs
Borrowings threshold consecutive trading days for redemption
Borrowings Threshold Consecutive Trading Days For Redemption
Borrowings threshold consecutive trading days for redemption.
Total non-current liabilities
Non-current liabilities
China [member]
CHINA
Impairment charge
Impairment loss recognised in profit or loss, property, plant and equipment
Impairment loss recognised in profit or loss, property, plant and equipment
Total equity and liabilities
Equity and liabilities
Derivative Financial Liabilities at Fair Value Settled
Settled
Derivative financial liabilities at fair value settled.
Total financial liabilities
Financial liabilities
Statement of financial position [abstract]
Document Fiscal Year Focus
Significant events in the reporting period.
Significant Events in the Reporting Period [Abstract]
Share nominal value
Par value per share
Nominal value per share
Cash and cash equivalents
Total cash and cash equivalents
Cash and cash equivalents
Cash and cash equivalents
Cash and cash equivalents at January 1
Cash and cash equivalents at March 31
Restricted stock units.
Restricted Stock Units [Member]
Disclosure of summary of significant accounting policies [line items]
Disclosure Of Summary Of Significant Accounting Policies [line items]
Line items representing the disclosure of summary of significant accounting policies.
Beginning balance
Ending balance
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement
Disclosure of operating segments [abstract]
Equity and liabilities
Equity and liabilities [abstract]
Classes of other provisions [axis]
Current derivative financial liabilities
Derivative liabilities
Amortization
Adjustments for amortisation expense
Liabilities
Total liabilities
Liabilities at beginning of period
Liabilities at end of period
Liabilities
Profit (loss) from operating activities
Operating profit/(loss)
Share Price Of Entity
Share price of entity.
Share price
Classification Of Related Party [Axis]
Classification Of Related Party [Axis]
Categories of related parties [domain]
Two Thousand and Twenty seven.
Two Thousand and Twenty seven [Member]
2027
Disclosure of employee compensation costs [abstract]
Disclosure of employees compensation costs.
Notes and debentures issued
Convertible senior notes
Types of antidilutive instruments [axis]
Disclosure of fair value measurement of liabilities [table]
General Information
Disclosure of general information about financial statements [text block]
Exercised during the period
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement
Levels of fair value hierarchy [domain]
Royalty Pharma U.S. Skytrofa [member]
Royalty Pharma United States Skytrofa.
Royalty Pharma United States Skytrofa [Member]
Comprehensive income
Total comprehensive income/(loss)
Net cash flows from (used in) investing activities
Cash flows from (used in) investing activities
Cash flows from/(used in) investing activities
New Share Repurchase Program [Member]
New share repurchase program.
New share repurchase program [member]
Finance income received
Finance income received, classified as operating activities
U.S. YORVIPATH [member]
United States Yorvipath [member]
U.S. YORVIPATH.
YORVIPATH [member]
Short Term Borrowing, Other
Short term borrowing, other
Borrowings
Total number of shares issued
Number of shares issued
Number of shares issued
Document Information [Line Items]
Convertible notes
Potential Conversion Of Convertible Senior Notes Into Number Of Ordinary Shares
Potential conversion of convertible senior notes into number of ordinary shares.
Classes of financial assets [domain]
Sharebased Payment Arrangement, Award type
Sharebased Payment Arrangement, Award type [Member]
Disclosure of non-adjusting events after reporting period [line items]
Range [axis]
Net gains (losses) on change in fair value of derivatives
Gains (losses) on change in fair value of derivatives
Gains (losses) on change in fair value of derivatives
Amount multiplied to purchase price minus revenue interest payments paid to purchaser on effective date of buy-out notice as buyout amount
Amount Multiplied to Purchase Price Minus Revenue Interest Payments Paid to Purchaser on Effective Date of Buy-out Notice As Buyout Amount
Amount multiplied to purchase price minus revenue interest payments paid to purchaser on effective date of buy-out notice as buyout amount.
Depreciation
Adjustments for depreciation expense
Disclosure of changes in accounting estimates [line items]
Number Of Treasury Shares Outstanding
Number of treasury shares outstanding.
March 31, 2025 (Holding)
January 1, 2025 (Holding)
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
Exchange differences on translating foreign operations
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
Distributable equity
Distributable equity
Distributable equity.
Exercise price of outstanding share options
Additions
Increase decrease in derivative financial liabilities fair value
Increase Decrease In Derivative Financial Liabilities Fair Value
Increase decrease in derivative financial liabilities fair value.
Basic and diluted earnings / (loss) per share
Basic And Diluted Earnings Loss Per Shares
Basic And Diluted Earnings Loss Per Shares
Finance expenses paid
Finance costs paid, classified as operating activities
Carrying amount of equity method investment
Investments accounted for using equity method
Total investments accounted for using equity method
Marketable securities.
Marketable securities1
Marketable securities
Net profit/(loss) for the period
Profit (loss)
Net profit/(loss) for the period
Net profit/(loss) for the period
Geographical areas [axis]
Geographical areas [axis]
Net cash flows from (used in) operations
Cash flows from (used in) operations
Cash flows generated from/(used in) operations
Exercised during the period
Vested at the reporting date
Number of other equity instruments exercised or vested in share-based payment arrangement
Specified by vesting year
Current tax liabilities
Income tax payables
Foreign Currency Conversion Option [Member]
Foreign Currency Conversion Option.
Goods or services transferred at point in time [member]
Income taxes refund (paid)
Income taxes paid (refund), classified as operating activities
Income taxes received/(paid)
Borrowings, maturity
Levels of fair value hierarchy [axis]
Maturity [axis]
Disclosure Of Holding Of Treasury Shares [Abstract]
Disclosure of holding of treasury shares.
Income statement.
Income Statement [Member]
Financial liabilities at amortised cost, Total
Financial liabilities measured at amortized cost
Financial liabilities at amortised cost
Movements in Level 3 Fair Value Measurements
Disclosure of Movements in Level Three Fair Value Measurements [Table Text Block]
Disclosure of movements in level 3 fair value measurements.
Disclosure of segment revenues by destination of major customers explanatory.
Disclosure of segment revenues by destination of major customers explanatory
Schedule of Revenue Recognized in Unaudited Condensed Consolidated Interim Statements of Profit or Loss
Maturity [domain]
North America [member]
North America [Member]
Shares Agreement Description
Shares agreement description.
Shares agreement description
Goods or services transferred over time [member]
Level 1 [member]
Level 1 of fair value hierarchy [member]
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of terms and conditions of share-based payment arrangement [table]
Net cash flows from (used in) financing activities
Cash flows from (used in) financing activities
Cash flows from/(used in) financing activities
Rest of world.
Rest of world [member]
Rest of World [member]
Unobservable inputs [axis]
Borrowings redemption period
Borrowings Redemption Period
Borrowings redemption period.
Changes in working capital:
Changes in working capital [abstract]
Changes in working capital.
Total financial liabilities at fair value through profit or loss
Financial liabilities measured at fair value through profit or loss
Financial liabilities at fair value through profit or loss
Lease liabilities
Contractual Undiscounted Cashflow Of Financial Lease Liabilities
Contractual undiscounted cashflow of Financial lease liabilities.
Two Thousand And Twenty Eight [member]
Two thousand and twenty eight.
2028
Exchange rate for percentage of revenue to royalty payment.
Revenue interest payment in percentage in exchange for funding
Revenue interest payment in percentage in exchange for funding
DENMARK
Denmark [member]
Description of vesting requirements for share-based payment arrangement
Description of vesting
Royalties and milestones.
Royalties and Milestones [Member]
Royalties And Milestones [Member]
Trade receivables
Trade receivables from associate
Trade receivables
Disclosure of transactions between related parties [table]
Range [domain]
Fixed interest rate [Member]
Fixed interest rate [member]
Total revenue
Total revenue
Revenue
Revenue
Cost of capital increase
Costs of capital increase (decrease)
Costs of capital increase (decrease).
Items that may be reclassified subsequently to profit or (loss):
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Net settlement under stock incentive programs
Net settlement under stock incentive programs.
Net settlement under stock incentive programs
Financial Assets and Liabilities
Disclosure of financial instruments [text block]
Types of interest rates [domain]
Settlement of marketable securities
Proceeds from sales or maturity of financial instruments, classified as investing activities
Measurement [domain]
Shares authorized to repurchase
Shares Authorized To Repurchase
Shares authorized to repurchase.
Disclosure of terms and conditions of share-based payment arrangement [line items]
Level 3 [member]
Level 3 of fair value hierarchy [member]
Measurement [axis]
Classes of financial assets [axis]
Reconciliation of changes in fair value measurement, liabilities [abstract]
Trade payables and accrued expenses
Current trade payables
Commercial customers [Member]
Commercial Customers.
Commercial customers [member]
Disclosure of classes of share capital [table]
Timing of transfer of goods or services [axis]
Subclassifications of assets, liabilities and equities [abstract]